Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2023-08-15 00:00:00 ET · period of report 2023-08-14 · accession 0001689325-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-15 | 2023-08-14 | ANIP | Pera Antonio R | Dir | S - Sale | $60.37 | -3,000 | 33.6K | -8% | -$181.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-14 | S | D | 3,000 | $60.37 | 33,627 | D | — | — | (F1) Reflects the weighted average price of sales on August 14, 2023. The shares were sold in multiple transactions at prices ranging from $60.12 to $60.83, inclusive. |